icad — Merger or Acquisition (April 2025)
23 slides from icad's merger presentation, Apr 17, 2025
Slide 1: Media Roundtable: Accelerating AI-Powered Early Detection and Diagnosis of Breast Cancer
April 16, 2025 | 12:00 ET Media Roundtable Accelerating AI - Powered Early Detection and Diagnosis of Breast Cancer
Slide 2: No Offer or Solicitation
No Offer or Solicitation This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or s
Slide 3: Forward-Looking Statements
Forward - Looking Statements This communication contains certain “forward - looking statements” within the meaning of the safe harbor provisions of the U . S . Private Securities Litigation Reform Act of 1995 , Section 27 A of the Securities Act and Section 21 E of the Securities Exchange Act of 193
Slide 4: Speakers
Kees Wesdorp, PhD President and Chief Executive Officer DeepHealth Greg Sorensen, MD Chief Science Officer RadNet, Inc. Speakers Dana Brown President, CEO, and Chairman of the Board iCAD, Inc. Sham Sokka, PhD Chief Operating and Technology Officer DeepHealth
Slide 5: Agenda
Agenda 01 RadNet Vision and DeepHealth Mission in Breast Health [10 min] Gregory Sorensen, MD, Chief Science Officer, RadNet, Inc. Kees Wesdorp, PhD, President and CEO, DeepHealth 02 03 Q&A [10 min] iCAD Acquisition Accelerating our Mission [17 min] Kees Wesdorp, PhD, President and CEO, DeepHealth P
Slide 6: RadNet and DeepHealth Vision
01 RadNet and DeepHealth Vision
Slide 7: RadNet - A national leader in diagnostic imaging services and digital health solutions
RadNet - A national leader in diagnostic imaging services and digital health solutions Worldwide Leader in Imaging AI State - of - the - art AI tools for breast, lung, and prostate cancer screening Industry Leading IT Solutions Complete viewing, scheduling, patient outreach tracking, image storage,
Slide 8: RadNet already demonstrates leadership in earlier and more accurate breast cancer detection
• RadNet performs ~1.9M mammograms per year, 4.4% of all mammograms in US , and 50,000+ breast biopsies per year • RadNet’s Enhanced Breast Cancer Detection program – powered by DeepHealth’s SmartMammo AI – enables 21% higher cancer detection rate 1 across all races and ages and lowers recall rates
Slide 9: RadNet already demonstrates leadership in earlier and more accurate breast cancer detection
• RadNet performs ~1.9M mammograms per year, 4.4% of all mammograms in US , and 50,000+ breast biopsies per year • RadNet’s Enhanced Breast Cancer Detection program – powered by DeepHealth’s SmartMammo AI – enables 21% higher cancer detection rate 1 across all races and ages and lowers recall rates
Slide 10: Empowering breakthroughs in care through imaging - Our mission
Empowering breakthroughs in care through imaging Our mission
Slide 11: Global leader in AI-powered health informatics
Global leader in AI - powered health informatics 400+ Customers worldwide* Integrating capabilities Diverse patient data Large data sets enable development, validation, and impact across diverse patient populations Global footprint with local clinical expertise RadNet’s Digital Health segment * Dire
Slide 12: Our unique capabilities
Our unique capabilities Delivering at scale Vertically integrated Clinically proven 1.3M+ AI - powered diagnoses per year 20M+ Managed imaging studies per year 300+ AI - powered cancer screening sites in the US and Europe Demonstrated clinical impact, e.g., 21% increase in breast cancer detection ra
Slide 13: Empowering 300+ sites globally
Empowering 300+ sites globally Delivering meaningful impact through AI - powered screening at scale 12 Leading breast cancer screening in the USA 260+ clinical sites Leading lung cancer screening in Europe 50+ clinical sites
Slide 14: iCAD Acquisition Accelerating our Mission
02 iCAD Acquisition Accelerating our Mission
Slide 15: RadNet has signed a definitive agreement to acquire iCAD
The acquisition will strengthen RadNet’s DeepHealth leadership in AI - driven Breast Cancer solutions by: • Accelerating scale across commercial, product, and engineering functions to meet growing market demand. • Expanding reach to a combined 10 million annual mammograms, over 1,700 provider sites,
Slide 16: iCAD, a global leader in AI-powered breast health solutions
Annual Revenue $19.6M FY 24 Their ProFound AI ® Breast Health Suite is a highly accurate, clinically validated, concurrent AI reader designed to assist in early breast cancer detection, density assessment, and short - term risk by analysing mammogram images in real time. 50+ Countries Served 1.5K+ H
Slide 17: Financial Overview
• 2024 actuals: $19.6M • Following the acquisition expected positive Adjusted EBITDA run rate by end of 2026 2 • 2025 guidance: $80 - 90M 1 • 2025 guidance: $15 - 17M Adjusted EBITDA 1 2 Revenue Earnings 1 Guidance issued as of February 27, 2025, and not being reaffirmed or updated hereby. 2 Adjuste
Slide 18: Acquisition expected to create attractive potential synergies
Commercial synergies Cost synergies • DeepHealth offerings into iCAD installed base • Access to 50+ countries, European growth acceleration in screening solutions • Shared funnel opportunities • $7M+ run rate cost synergies identified: ~$4M direct savings, e.g., board of directors, public company co
Slide 19: iCAD personnel expected to accelerate DeepHealth's growth plans
• Strong track record with global reach to develop, market, deploy, and service AI solutions at scale. • Partially fulfilling pre - existing hiring plans of DeepHealth to drive external growth. 26 FTE 26 FTE 14 FTE Product and R&D* Commercial** iCAD workforce, total 66 FTE 1 Support functions * Incl
Slide 20: Most comprehensive Breast AI Portfolio
Integrated Viewing & Reporting AI - powered Cancer Detection End to End Solution for Screening 1 Previously known as Assure. Safeguard Review Most comprehensive Breast AI Portfolio From AI only to complete technology stack for screening Value Clinical Impact Workflow Efficiency Revenue Generation Pr
Slide 21: Portfolio of solutions
Portfolio of solutions Improving operational efficiency, clinical excellence, and the delivery of care Lung Profound & SmartMammo TM Prostate Brain Operations Suite TM Diagnostic Suite TM Tech Live TM RIS/PACS Enterprise Imaging Population Health
Slide 22: Q&A
Q&A
Slide 23: DeepHealth
deephealth